AGT and atherosclerosis: Whole-body reduction of AGT, hepatocyte-specific AGT deficiency (hepAGT−/−), and global AGT antisense oligonucleotides (ASO) exerted similar effects on BP and atherosclerosis in LDL receptor−/− mice[8].